These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33060101)

  • 1. Centrally Reduced Diffusion Sign for Differentiation between Treatment-Related Lesions and Glioma Progression: A Validation Study.
    Alcaide-Leon P; Cluceru J; Lupo JM; Yu TJ; Luks TL; Tihan T; Bush NA; Villanueva-Meyer JE
    AJNR Am J Neuroradiol; 2020 Nov; 41(11):2049-2054. PubMed ID: 33060101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of Centrally Restricted Diffusion in the Differentiation of Treatment-Related Necrosis from Tumor Recurrence in High-Grade Gliomas.
    Zakhari N; Taccone MS; Torres C; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Nguyen TB
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):260-264. PubMed ID: 29217742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric Evaluation in Differentiating Glioma Recurrence from Treatment-Induced Necrosis Using Simultaneous
    Jena A; Taneja S; Jha A; Damesha NK; Negi P; Jadhav GK; Verma SM; Sogani SK
    AJNR Am J Neuroradiol; 2017 May; 38(5):899-907. PubMed ID: 28341716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Accuracy of Centrally Restricted Diffusion Sign in Cerebral Metastatic Disease: Differentiating Radiation Necrosis from Tumor Recurrence.
    Puac-Polanco P; Zakhari N; Miller J; McComiskey D; Thornhill RE; Jansen GH; Nair VJ; Nguyen TB
    Can Assoc Radiol J; 2023 Feb; 74(1):100-109. PubMed ID: 35848632
    [No Abstract]   [Full Text] [Related]  

  • 5. Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression.
    Yu Y; Ma Y; Sun M; Jiang W; Yuan T; Tong D
    Medicine (Baltimore); 2020 Jun; 99(23):e20270. PubMed ID: 32501974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential for differentiation of glioma recurrence from radionecrosis using integrated
    Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
    Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors.
    Matsunaga S; Shuto T; Takase H; Ohtake M; Tomura N; Tanaka T; Sonoda M
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):47-52. PubMed ID: 22541963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
    Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
    J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma.
    Barajas RF; Butowski NA; Phillips JJ; Aghi MK; Berger MS; Chang SM; Cha S
    Acad Radiol; 2016 Sep; 23(9):1073-82. PubMed ID: 27443507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery.
    Hainc N; Alsafwani N; Gao A; O'Halloran PJ; Kongkham P; Zadeh G; Gutierrez E; Shultz D; Krings T; Alcaide-Leon P
    J Neurooncol; 2021 Dec; 155(3):325-333. PubMed ID: 34689307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of residual/recurrent gliomas from postradiation necrosis with arterial spin labeling and diffusion tensor magnetic resonance imaging-derived metrics.
    Razek AAKA; El-Serougy L; Abdelsalam M; Gaballa G; Talaat M
    Neuroradiology; 2018 Feb; 60(2):169-177. PubMed ID: 29218370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
    Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
    Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
    Takenaka S; Asano Y; Shinoda J; Nomura Y; Yonezawa S; Miwa K; Yano H; Iwama T
    Neurol Med Chir (Tokyo); 2014; 54(4):280-9. PubMed ID: 24305028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histogram analysis of diffusion kurtosis imaging derived maps may distinguish between low and high grade gliomas before surgery.
    Qi XX; Shi DF; Ren SX; Zhang SY; Li L; Li QC; Guan LM
    Eur Radiol; 2018 Apr; 28(4):1748-1755. PubMed ID: 29143940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas.
    Yang Y; Yang Y; Wu X; Pan Y; Zhou D; Zhang H; Chen Y; Zhao J; Mo Z; Huang B
    J Neurooncol; 2020 Jan; 146(2):363-371. PubMed ID: 31902040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Low- and High-Grade Gliomas Using High b-Value Diffusion Imaging with a Non-Gaussian Diffusion Model.
    Sui Y; Xiong Y; Jiang J; Karaman MM; Xie KL; Zhu W; Zhou XJ
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1643-9. PubMed ID: 27256851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential Apparent Diffusion Coefficient for Assessment of Tumor Progression in Patients with Low-Grade Glioma.
    Chen IE; Swinburne N; Tsankova NM; Hefti MM; Aggarwal A; Doshi AH; Hormigo A; Delman BN; Nael K
    AJNR Am J Neuroradiol; 2018 Jun; 39(6):1039-1046. PubMed ID: 29674411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma Recurrence Versus Radiation Necrosis: Single-Session Multiparametric Approach Using Simultaneous O-(2-18F-Fluoroethyl)-L-Tyrosine PET/MRI.
    Jena A; Taneja S; Gambhir A; Mishra AK; Dʼsouza MM; Verma SM; Hazari PP; Negi P; Jhadav GK; Sogani SK
    Clin Nucl Med; 2016 May; 41(5):e228-36. PubMed ID: 26859208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.